234 related articles for article (PubMed ID: 9649136)
1. Suppression of tumorigenic and metastatic potentials of human melanoma cell lines by mutated (143 Val-Ala) p53.
Rauth S; Green A; Kichina J; Shilkaitis A
Br J Cancer; 1998 Jun; 77(12):2215-22. PubMed ID: 9649136
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a human melanoma cell line lacking p53 expression and spontaneously metastasizing in nude mice.
Rauth S; Kichina J; Green A; Bratescu L; Das Gupta TK
Anticancer Res; 1994; 14(6B):2457-63. PubMed ID: 7872667
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated gene transfer of wild-type p53 results in melanoma cell apoptosis in vitro and in vivo.
Cirielli C; Riccioni T; Yang C; Pili R; Gloe T; Chang J; Inyaku K; Passaniti A; Capogrossi MC
Int J Cancer; 1995 Nov; 63(5):673-9. PubMed ID: 7591284
[TBL] [Abstract][Full Text] [Related]
4. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
Xie S; Price JE; Luca M; Jean D; Ronai Z; Bar-Eli M
Oncogene; 1997 Oct; 15(17):2069-75. PubMed ID: 9366524
[TBL] [Abstract][Full Text] [Related]
5. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells.
Jiang H; Lin J; Su ZZ; Herlyn M; Kerbel RS; Weissman BE; Welch DR; Fisher PB
Oncogene; 1995 May; 10(9):1855-64. PubMed ID: 7753561
[TBL] [Abstract][Full Text] [Related]
6. Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1.
Williams AC; Browne SJ; Manning AM; Daffada P; Collard TJ; Paraskeva C
Oncogene; 1994 May; 9(5):1479-85. PubMed ID: 8152811
[TBL] [Abstract][Full Text] [Related]
7. Wild-type p53 gene transfer inhibits invasion and reduces matrix metalloproteinase-2 levels in p53-mutated human melanoma cells.
Toschi E; Rota R; Antonini A; Melillo G; Capogrossi MC
J Invest Dermatol; 2000 Jun; 114(6):1188-94. PubMed ID: 10844565
[TBL] [Abstract][Full Text] [Related]
8. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines.
Janicek MF; Angioli R; Unal AD; Sevin BU; Madrigal M; Estape R; Averette HE
Gynecol Oncol; 1997 Jul; 66(1):94-102. PubMed ID: 9234928
[TBL] [Abstract][Full Text] [Related]
9. Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1.
Gerwin BI; Spillare E; Forrester K; Lehman TA; Kispert J; Welsh JA; Pfeifer AM; Lechner JF; Baker SJ; Vogelstein B
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2759-63. PubMed ID: 1557382
[TBL] [Abstract][Full Text] [Related]
10. Stimulatory effect of reconstituted basement membrane components (matrigel) on the colony formation of a panel of human lung cancer cell lines in soft agar.
Yoshida S; Shimizu E; Ogura T; Takada M; Sone S
J Cancer Res Clin Oncol; 1997; 123(6):301-9. PubMed ID: 9222295
[TBL] [Abstract][Full Text] [Related]
11. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.
Zhang WW; Fang X; Mazur W; French BA; Georges RN; Roth JA
Cancer Gene Ther; 1994 Mar; 1(1):5-13. PubMed ID: 7621238
[TBL] [Abstract][Full Text] [Related]
12. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
Gershenwald JE; Sumner W; Calderone T; Wang Z; Huang S; Bar-Eli M
Oncogene; 2001 Jun; 20(26):3363-75. PubMed ID: 11423987
[TBL] [Abstract][Full Text] [Related]
13. Effects of inoculation site and Matrigel on growth and metastasis of human breast cancer cells.
Bao L; Matsumura Y; Baban D; Sun Y; Tarin D
Br J Cancer; 1994 Aug; 70(2):228-32. PubMed ID: 8054270
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of mutant p53 and c-erbB-2 proteins and breast tumour take in mice.
Mehta RR; Graves JM; Warso MA; Das Gupta TK
Br J Cancer; 1995 Nov; 72(5):1160-4. PubMed ID: 7577462
[TBL] [Abstract][Full Text] [Related]
15. Wild-type p53 and a p53 temperature-sensitive mutant suppress human soft tissue sarcoma by enhancing cell cycle control.
Pollock R; Lang A; Ge T; Sun D; Tan M; Yu D
Clin Cancer Res; 1998 Aug; 4(8):1985-94. PubMed ID: 9717829
[TBL] [Abstract][Full Text] [Related]
16. Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer.
Yamada T; Goto M; Punj V; Zaborina O; Chen ML; Kimbara K; Majumdar D; Cunningham E; Das Gupta TK; Chakrabarty AM
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14098-103. PubMed ID: 12393814
[TBL] [Abstract][Full Text] [Related]
17. Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.
Huang S; Jean D; Luca M; Tainsky MA; Bar-Eli M
EMBO J; 1998 Aug; 17(15):4358-69. PubMed ID: 9687504
[TBL] [Abstract][Full Text] [Related]
18. Mutant p53 melanoma cell lines respond differently to CP-31398-induced apoptosis.
Ho CK; Li G
Br J Dermatol; 2005 Nov; 153(5):900-10. PubMed ID: 16225598
[TBL] [Abstract][Full Text] [Related]
19. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
Wang H; Lai B; Li J
Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
[TBL] [Abstract][Full Text] [Related]
20. Melanoma heterogeneity: differential, invasive, metastatic properties and profiles of cathepsin B, D and L activities in subclones of the B16F10-NEX2 cell line.
Freitas ZF; Rodrigues EG; Oliveira V; Carmona AK; Travassos LR
Melanoma Res; 2004 Oct; 14(5):333-44. PubMed ID: 15457088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
